NPM1 and acute myeloid leukemia: In this study, we investigated whether different immunotherapeutics alone or in combination with anti-PD-1 can further enhance the LPC/CFC degradation of NPM1mut AML in comparison to AML cells with a wild type NPM1 gene (NPM1WT).